Therapeutic Efficacy of Adoptive Cell Transfer on Survival of Patients with Glioblastoma Multiforme: Case Reports

Glioblastoma multiforme (GBM), which occurs mostly in individuals over the age of 40, accounts for 12–15% of all primary brain tumors. Patients with GBM have a poor prognosis, even after aggressive upfront therapies. The present study documents that in 5 of these patients, the use of a novel immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Katakura, Ryuichi, Suzuki, Youichi, Sekine, Teruaki, Sasaki, Yu F., Fujimiya, Yoshiaki
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: April 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919986/
https://www.ncbi.nlm.nih.gov/pubmed/20740183
http://dx.doi.org/10.1159/000313629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919986/
https://www.ncbi.nlm.nih.gov/pubmed/20740183
http://dx.doi.org/10.1159/000313629

Ejemplares similares